Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Howard Bradley Schiller currently holds 336,784 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Howard Bradley Schiller has been a net buyer of VRX stock. They have purchased $5.0M and sold $0 worth of shares.
Howard Bradley Schiller's most recent insider trade was on Feb 18, 2016, when they sold 51,846 shares at $91.45 per share.
Howard Bradley Schiller serves as Executive at Valeant Pharmaceuticals International, Inc. (VRX). They have executed 31 insider transactions totaling $5.0M over their tenure at the company.
Howard Bradley Schiller holds the position of Executive at Valeant Pharmaceuticals International, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Howard Bradley Schiller has shown a buying trading pattern, with $5.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Howard Bradley Schiller was on Feb 18, 2016, when they sold $4.7M worth of VRX shares. This transaction involved 51,846 shares at $91.45 per share.
Howard Bradley Schiller currently owns 336,784 shares of Valeant Pharmaceuticals International, Inc. (VRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Howard Bradley Schiller's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Howard Bradley Schiller has 31 Form 4 filings on record as an insider at Valeant Pharmaceuticals International, Inc..
Set alerts for Howard Bradley Schiller and 40,000+ other insiders.